D-0446-2017 Class III Terminated
FDA drug recall D-0446-2017 was initiated by Sun Pharmaceutical Industries, Inc. on Dec 20, 2016 and is designated Class III. Reason for recall: Failed Dissolution Specifications; 18 month stability time point The recall status is terminated (terminated Jul 11, 2018). Affected quantity: 11,618 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 1, 2017
- Initiation Date
- Dec 20, 2016
- Termination Date
- Jul 11, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 11,618 bottles
Product description
buPROPion Hydrochloride Extended-release Tablets, USP (SR), 200 mg, 60 count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India NDC 47335-0738-86
Reason for recall
Failed Dissolution Specifications; 18 month stability time point
Distribution pattern
Nationwide
Code information
JKP0905A 04/17
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0446-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026